Radiomics and MGMT promoter methylation for prognostication of newly diagnosed glioblastoma

We attempted to establish a magnetic resonance imaging (MRI)-based radiomic model for stratifying prognostic subgroups of newly diagnosed glioblastoma (GBM) patients and predicting O (6)-methylguanine-DNA methyltransferase promotor methylation (pMGMT-met) status of the tumor. Preoperative MRI scans...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Takahiro, Kinoshita, Manabu, Fujita, Koji, Fukai, Junya, Hayashi, Nobuhide, Uematsu, Yuji, Okita, Yoshiko, Nonaka, Masahiro, Moriuchi, Shusuke, Uda, Takehiro, Tsuyuguchi, Naohiro, Arita, Hideyuki, Mori, Kanji, Ishibashi, Kenichi, Takano, Koji, Nishida, Namiko, Shofuda, Tomoko, Yoshioka, Ema, Kanematsu, Daisuke, Kodama, Yoshinori, Mano, Masayuki, Nakao, Naoyuki, Kanemura, Yonehiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783410/
https://www.ncbi.nlm.nih.gov/pubmed/31594994
http://dx.doi.org/10.1038/s41598-019-50849-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783410/
https://www.ncbi.nlm.nih.gov/pubmed/31594994
http://dx.doi.org/10.1038/s41598-019-50849-y

Ejemplares similares